Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Mol Cell Biol. 1993 Jul; 13(7): 4125–4136.
doi: 10.1128/mcb.13.7.4125
PMCID: PMC359962
PMID: 8321217

Cell cycle regulation of the c-Myc transcriptional activation domain.

A Seth, S Gupta, and R J Davis
Author information Copyright and License information Disclaimer

Abstract

The product of the c-myc gene (c-Myc) is a sequence-specific DNA-binding protein that has previously been demonstrated to be required for cell cycle progression. Here we report that the c-Myc DNA binding site confers cell cycle regulation to a reporter gene in Chinese hamster ovary cells. The observed transactivation was biphasic with a small increase in G1 and a marked increase during the S-to-G2/M transition of the cell cycle. This cell cycle regulation of transactivation potential is accounted for, in part, by regulatory phosphorylation of the c-Myc transactivation domain. Together, these data demonstrate that c-Myc may have an important role in the progression of cells through both the G1 and G2 phases of the cell cycle.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

 
icon of scanned page 4125
4125
icon of scanned page 4126
4126
icon of scanned page 4127
4127
icon of scanned page 4128
4128
icon of scanned page 4129
4129
icon of scanned page 4130
4130
icon of scanned page 4131
4131
icon of scanned page 4132
4132
icon of scanned page 4133
4133
icon of scanned page 4134
4134
icon of scanned page 4135
4135
icon of scanned page 4136
4136
 

Images in this article

Image

Image
on p.4129

Image

Image
on p.4131

Image

Image
on p.4131

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  • Adams RL, Lindsay JG. Hydroxyurea reversal of inhibition and use as a cell-synchronizing agent. J Biol Chem. 1967 Mar 25;242(6):1314–1317. [PubMed] [Google Scholar]
  • Alvarez E, Northwood IC, Gonzalez FA, Latour DA, Seth A, Abate C, Curran T, Davis RJ. Pro-Leu-Ser/Thr-Pro is a consensus primary sequence for substrate protein phosphorylation. Characterization of the phosphorylation of c-myc and c-jun proteins by an epidermal growth factor receptor threonine 669 protein kinase. J Biol Chem. 1991 Aug 15;266(23):15277–15285. [PubMed] [Google Scholar]
  • Amati B, Brooks MW, Levy N, Littlewood TD, Evan GI, Land H. Oncogenic activity of the c-Myc protein requires dimerization with Max. Cell. 1993 Jan 29;72(2):233–245. [PubMed] [Google Scholar]
  • Amati B, Dalton S, Brooks MW, Littlewood TD, Evan GI, Land H. Transcriptional activation by the human c-Myc oncoprotein in yeast requires interaction with Max. Nature. 1992 Oct 1;359(6394):423–426. [PubMed] [Google Scholar]
  • Amin C, Wagner AJ, Hay N. Sequence-specific transcriptional activation by Myc and repression by Max. Mol Cell Biol. 1993 Jan;13(1):383–390. [PMC free article] [PubMed] [Google Scholar]
  • Armelin HA, Armelin MC, Kelly K, Stewart T, Leder P, Cochran BH, Stiles CD. Functional role for c-myc in mitogenic response to platelet-derived growth factor. Nature. 1984 Aug 23;310(5979):655–660. [PubMed] [Google Scholar]
  • Ayer DE, Kretzner L, Eisenman RN. Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell. 1993 Jan 29;72(2):211–222. [PubMed] [Google Scholar]
  • Bar-Ner M, Messing LT, Cultraro CM, Birrer MJ, Segal S. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells. Cell Growth Differ. 1992 Mar;3(3):183–190. [PubMed] [Google Scholar]
  • Barrett CB, Erikson E, Maller JL. A purified S6 kinase kinase from Xenopus eggs activates S6 kinase II and autophosphorylates on serine, threonine, and tyrosine residues. J Biol Chem. 1992 Mar 5;267(7):4408–4415. [PubMed] [Google Scholar]
  • Berberich SJ, Cole MD. Casein kinase II inhibits the DNA-binding activity of Max homodimers but not Myc/Max heterodimers. Genes Dev. 1992 Feb;6(2):166–176. [PubMed] [Google Scholar]
  • Birrer MJ, Raveh L, Dosaka H, Segal S. A transfected L-myc gene can substitute for c-myc in blocking murine erythroleukemia differentiation. Mol Cell Biol. 1989 Jun;9(6):2734–2737. [PMC free article] [PubMed] [Google Scholar]
  • Bissonnette RP, Echeverri F, Mahboubi A, Green DR. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature. 1992 Oct 8;359(6395):552–554. [PubMed] [Google Scholar]
  • Blackwell TK, Kretzner L, Blackwood EM, Eisenman RN, Weintraub H. Sequence-specific DNA binding by the c-Myc protein. Science. 1990 Nov 23;250(4984):1149–1151. [PubMed] [Google Scholar]
  • Blackwood EM, Eisenman RN. Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science. 1991 Mar 8;251(4998):1211–1217. [PubMed] [Google Scholar]
  • Blackwood EM, Kretzner L, Eisenman RN. Myc and Max function as a nucleoprotein complex. Curr Opin Genet Dev. 1992 Apr;2(2):227–235. [PubMed] [Google Scholar]
  • Blackwood EM, Lüscher B, Eisenman RN. Myc and Max associate in vivo. Genes Dev. 1992 Jan;6(1):71–80. [PubMed] [Google Scholar]
  • Boulton TG, Nye SH, Robbins DJ, Ip NY, Radziejewska E, Morgenbesser SD, DePinho RA, Panayotatos N, Cobb MH, Yancopoulos GD. ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGF. Cell. 1991 May 17;65(4):663–675. [PubMed] [Google Scholar]
  • Boulton TG, Yancopoulos GD, Gregory JS, Slaughter C, Moomaw C, Hsu J, Cobb MH. An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle control. Science. 1990 Jul 6;249(4964):64–67. [PubMed] [Google Scholar]
  • Clark-Lewis I, Sanghera JS, Pelech SL. Definition of a consensus sequence for peptide substrate recognition by p44mpk, the meiosis-activated myelin basic protein kinase. J Biol Chem. 1991 Aug 15;266(23):15180–15184. [PubMed] [Google Scholar]
  • Coffey RJ, Jr, Bascom CC, Sipes NJ, Graves-Deal R, Weissman BE, Moses HL. Selective inhibition of growth-related gene expression in murine keratinocytes by transforming growth factor beta. Mol Cell Biol. 1988 Aug;8(8):3088–3093. [PMC free article] [PubMed] [Google Scholar]
  • Cole MD. The myc oncogene: its role in transformation and differentiation. Annu Rev Genet. 1986;20:361–384. [PubMed] [Google Scholar]
  • Cole MD. Myc meets its Max. Cell. 1991 May 31;65(5):715–716. [PubMed] [Google Scholar]
  • Coppola JA, Cole MD. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment. Nature. 1986 Apr 24;320(6064):760–763. [PubMed] [Google Scholar]
  • Countaway JL, Northwood IC, Davis RJ. Mechanism of phosphorylation of the epidermal growth factor receptor at threonine 669. J Biol Chem. 1989 Jun 25;264(18):10828–10835. [PubMed] [Google Scholar]
  • Coyle MB, Strauss B. Cell killing and the accumulation of breaks in the DNA of HEp-2 cells incubated in the presence of hydroxyurea. Cancer Res. 1970 Sep;30(9):2314–2319. [PubMed] [Google Scholar]
  • Dalton S. Cell cycle regulation of the human cdc2 gene. EMBO J. 1992 May;11(5):1797–1804. [PMC free article] [PubMed] [Google Scholar]
  • Dean M, Levine RA, Ran W, Kindy MS, Sonenshein GE, Campisi J. Regulation of c-myc transcription and mRNA abundance by serum growth factors and cell contact. J Biol Chem. 1986 Jul 15;261(20):9161–9166. [PubMed] [Google Scholar]
  • DeCaprio JA, Ludlow JW, Lynch D, Furukawa Y, Griffin J, Piwnica-Worms H, Huang CM, Livingston DM. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell. 1989 Sep 22;58(6):1085–1095. [PubMed] [Google Scholar]
  • Dmitrovsky E, Kuehl WM, Hollis GF, Kirsch IR, Bender TP, Segal S. Expression of a transfected human c-myc oncogene inhibits differentiation of a mouse erythroleukaemia cell line. Nature. 1986 Aug 21;322(6081):748–750. [PubMed] [Google Scholar]
  • Dotto GP, Gilman MZ, Maruyama M, Weinberg RA. c-myc and c-fos expression in differentiating mouse primary keratinocytes. EMBO J. 1986 Nov;5(11):2853–2857. [PMC free article] [PubMed] [Google Scholar]
  • Downs KM, Martin GR, Bishop JM. Contrasting patterns of myc and N-myc expression during gastrulation of the mouse embryo. Genes Dev. 1989 Jun;3(6):860–869. [PubMed] [Google Scholar]
  • Dulić V, Lees E, Reed SI. Association of human cyclin E with a periodic G1-S phase protein kinase. Science. 1992 Sep 25;257(5078):1958–1961. [PubMed] [Google Scholar]
  • Eilers M, Picard D, Yamamoto KR, Bishop JM. Chimaeras of myc oncoprotein and steroid receptors cause hormone-dependent transformation of cells. Nature. 1989 Jul 6;340(6228):66–68. [PubMed] [Google Scholar]
  • Eilers M, Schirm S, Bishop JM. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 1991 Jan;10(1):133–141. [PMC free article] [PubMed] [Google Scholar]
  • Eisenman RN, Tachibana CY, Abrams HD, Hann SR. V-myc- and c-myc-encoded proteins are associated with the nuclear matrix. Mol Cell Biol. 1985 Jan;5(1):114–126. [PMC free article] [PubMed] [Google Scholar]
  • Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC. Induction of apoptosis in fibroblasts by c-myc protein. Cell. 1992 Apr 3;69(1):119–128. [PubMed] [Google Scholar]
  • Ferrell JE, Jr, Wu M, Gerhart JC, Martin GS. Cell cycle tyrosine phosphorylation of p34cdc2 and a microtubule-associated protein kinase homolog in Xenopus oocytes and eggs. Mol Cell Biol. 1991 Apr;11(4):1965–1971. [PMC free article] [PubMed] [Google Scholar]
  • Freytag SO, Dang CV, Lee WM. Definition of the activities and properties of c-myc required to inhibit cell differentiation. Cell Growth Differ. 1990 Jul;1(7):339–343. [PubMed] [Google Scholar]
  • Gille H, Sharrocks AD, Shaw PE. Phosphorylation of transcription factor p62TCF by MAP kinase stimulates ternary complex formation at c-fos promoter. Nature. 1992 Jul 30;358(6385):414–417. [PubMed] [Google Scholar]
  • Gonzalez FA, Raden DL, Davis RJ. Identification of substrate recognition determinants for human ERK1 and ERK2 protein kinases. J Biol Chem. 1991 Nov 25;266(33):22159–22163. [PubMed] [Google Scholar]
  • Goodrich DW, Lee WH. Abrogation by c-myc of G1 phase arrest induced by RB protein but not by p53. Nature. 1992 Nov 12;360(6400):177–179. [PubMed] [Google Scholar]
  • Gotoh Y, Moriyama K, Matsuda S, Okumura E, Kishimoto T, Kawasaki H, Suzuki K, Yahara I, Sakai H, Nishida E. Xenopus M phase MAP kinase: isolation of its cDNA and activation by MPF. EMBO J. 1991 Sep;10(9):2661–2668. [PMC free article] [PubMed] [Google Scholar]
  • Gotoh Y, Nishida E, Matsuda S, Shiina N, Kosako H, Shiokawa K, Akiyama T, Ohta K, Sakai H. In vitro effects on microtubule dynamics of purified Xenopus M phase-activated MAP kinase. Nature. 1991 Jan 17;349(6306):251–254. [PubMed] [Google Scholar]
  • Gupta S, Seth A, Davis RJ. Transactivation of gene expression by Myc is inhibited by mutation at the phosphorylation sites Thr-58 and Ser-62. Proc Natl Acad Sci U S A. 1993 Apr 15;90(8):3216–3220. [PMC free article] [PubMed] [Google Scholar]
  • Gurley LR, Walters RA, Tobey RA. Sequential phsophorylation of histone subfractions in the Chinese hamster cell cycle. J Biol Chem. 1975 May 25;250(10):3936–3944. [PubMed] [Google Scholar]
  • Gutman A, Wasylyk B. Nuclear targets for transcription regulation by oncogenes. Trends Genet. 1991 Feb;7(2):49–54. [PubMed] [Google Scholar]
  • Halazonetis TD, Kandil AN. Determination of the c-MYC DNA-binding site. Proc Natl Acad Sci U S A. 1991 Jul 15;88(14):6162–6166. [PMC free article] [PubMed] [Google Scholar]
  • Hann SR, Thompson CB, Eisenman RN. c-myc oncogene protein synthesis is independent of the cell cycle in human and avian cells. Nature. 314(6009):366–369. [PubMed] [Google Scholar]
  • Heikkila R, Schwab G, Wickstrom E, Loke SL, Pluznik DH, Watt R, Neckers LM. A c-myc antisense oligodeoxynucleotide inhibits entry into S phase but not progress from G0 to G1. Nature. 328(6129):445–449. [PubMed] [Google Scholar]
  • Holt JT, Redner RL, Nienhuis AW. An oligomer complementary to c-myc mRNA inhibits proliferation of HL-60 promyelocytic cells and induces differentiation. Mol Cell Biol. 1988 Feb;8(2):963–973. [PMC free article] [PubMed] [Google Scholar]
  • Hourdry J, Brulfert A, Gusse M, Schoevaert D, Taylor MV, Mechali M. Localization of c-myc expression during oogenesis and embryonic development in Xenopus laevis. Development. 1988 Dec;104(4):631–641. [PubMed] [Google Scholar]
  • Hunter T. Cooperation between oncogenes. Cell. 1991 Jan 25;64(2):249–270. [PubMed] [Google Scholar]
  • Hunter T, Karin M. The regulation of transcription by phosphorylation. Cell. 1992 Aug 7;70(3):375–387. [PubMed] [Google Scholar]
  • Jackson SP. Regulating transcription factor activity by phosphorylation. Trends Cell Biol. 1992 Apr;2(4):104–108. [PubMed] [Google Scholar]
  • Jaffredo T, Vandenbunder B, Dieterlen-Lièvre F. In situ study of c-myc protein expression during avian development. Development. 1989 Apr;105(4):679–695. [PubMed] [Google Scholar]
  • Kaelin WG, Jr, Pallas DC, DeCaprio JA, Kaye FJ, Livingston DM. Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product. Cell. 1991 Feb 8;64(3):521–532. [PubMed] [Google Scholar]
  • Karn J, Watson JV, Lowe AD, Green SM, Vedeckis W. Regulation of cell cycle duration by c-myc levels. Oncogene. 1989 Jun;4(6):773–787. [PubMed] [Google Scholar]
  • Kato GJ, Barrett J, Villa-Garcia M, Dang CV. An amino-terminal c-myc domain required for neoplastic transformation activates transcription. Mol Cell Biol. 1990 Nov;10(11):5914–5920. [PMC free article] [PubMed] [Google Scholar]
  • Kato GJ, Dang CV. Function of the c-Myc oncoprotein. FASEB J. 1992 Sep;6(12):3065–3072. [PubMed] [Google Scholar]
  • Kato GJ, Lee WM, Chen LL, Dang CV. Max: functional domains and interaction with c-Myc. Genes Dev. 1992 Jan;6(1):81–92. [PubMed] [Google Scholar]
  • Kelly K, Cochran BH, Stiles CD, Leder P. Cell-specific regulation of the c-myc gene by lymphocyte mitogens and platelet-derived growth factor. Cell. 1983 Dec;35(3 Pt 2):603–610. [PubMed] [Google Scholar]
  • Kerkhoff E, Bister K, Klempnauer KH. Sequence-specific DNA binding by Myc proteins. Proc Natl Acad Sci U S A. 1991 May 15;88(10):4323–4327. [PMC free article] [PubMed] [Google Scholar]
  • King MW, Roberts JM, Eisenman RN. Expression of the c-myc proto-oncogene during development of Xenopus laevis. Mol Cell Biol. 1986 Dec;6(12):4499–4508. [PMC free article] [PubMed] [Google Scholar]
  • Kretzner L, Blackwood EM, Eisenman RN. Myc and Max proteins possess distinct transcriptional activities. Nature. 1992 Oct 1;359(6394):426–429. [PubMed] [Google Scholar]
  • Kume TU, Takada S, Obinata M. Probability that the commitment of murine erythroleukemia cell differentiation is determined by the c-myc level. J Mol Biol. 1988 Aug 20;202(4):779–786. [PubMed] [Google Scholar]
  • Langdon WY, Harris AW, Cory S. Growth of E mu-myc transgenic B-lymphoid cells in vitro and their evolution toward autonomy. Oncogene Res. 1988;3(3):271–279. [PubMed] [Google Scholar]
  • Lin LL, Wartmann M, Lin AY, Knopf JL, Seth A, Davis RJ. cPLA2 is phosphorylated and activated by MAP kinase. Cell. 1993 Jan 29;72(2):269–278. [PubMed] [Google Scholar]
  • Lüscher B, Eisenman RN. New light on Myc and Myb. Part I. Myc. Genes Dev. 1990 Dec;4(12A):2025–2035. [PubMed] [Google Scholar]
  • Lüscher B, Eisenman RN. Mitosis-specific phosphorylation of the nuclear oncoproteins Myc and Myb. J Cell Biol. 1992 Aug;118(4):775–784. [PMC free article] [PubMed] [Google Scholar]
  • Lüscher B, Kuenzel EA, Krebs EG, Eisenman RN. Myc oncoproteins are phosphorylated by casein kinase II. EMBO J. 1989 Apr;8(4):1111–1119. [PMC free article] [PubMed] [Google Scholar]
  • Mäkelä TP, Koskinen PJ, Västrik I, Alitalo K. Alternative forms of Max as enhancers or suppressors of Myc-ras cotransformation. Science. 1992 Apr 17;256(5055):373–377. [PubMed] [Google Scholar]
  • Marcu KB, Bossone SA, Patel AJ. myc function and regulation. Annu Rev Biochem. 1992;61:809–860. [PubMed] [Google Scholar]
  • Maruyama K, Schiavi SC, Huse W, Johnson GL, Ruley HE. myc and E1A oncogenes alter the responses of PC12 cells to nerve growth factor and block differentiation. Oncogene. 1987;1(4):361–367. [PubMed] [Google Scholar]
  • Mittnacht S, Weinberg RA. G1/S phosphorylation of the retinoblastoma protein is associated with an altered affinity for the nuclear compartment. Cell. 1991 May 3;65(3):381–393. [PubMed] [Google Scholar]
  • Norbury C, Nurse P. Animal cell cycles and their control. Annu Rev Biochem. 1992;61:441–470. [PubMed] [Google Scholar]
  • Northwood IC, Gonzalez FA, Wartmann M, Raden DL, Davis RJ. Isolation and characterization of two growth factor-stimulated protein kinases that phosphorylate the epidermal growth factor receptor at threonine 669. J Biol Chem. 1991 Aug 15;266(23):15266–15276. [PubMed] [Google Scholar]
  • Palmieri S, Kahn P, Graf T. Quail embryo fibroblasts transformed by four v-myc-containing virus isolates show enhanced proliferation but are non tumorigenic. EMBO J. 1983;2(12):2385–2389. [PMC free article] [PubMed] [Google Scholar]
  • Papoulas O, Williams NG, Kingston RE. DNA binding activities of c-Myc purified from eukaryotic cells. J Biol Chem. 1992 May 25;267(15):10470–10480. [PubMed] [Google Scholar]
  • Pedrali-Noy G, Spadari S, Miller-Faurès A, Miller AO, Kruppa J, Koch G. Synchronization of HeLa cell cultures by inhibition of DNA polymerase alpha with aphidicolin. Nucleic Acids Res. 1980 Jan 25;8(2):377–387. [PMC free article] [PubMed] [Google Scholar]
  • Pietenpol JA, Münger K, Howley PM, Stein RW, Moses HL. Factor-binding element in the human c-myc promoter involved in transcriptional regulation by transforming growth factor beta 1 and by the retinoblastoma gene product. Proc Natl Acad Sci U S A. 1991 Nov 15;88(22):10227–10231. [PMC free article] [PubMed] [Google Scholar]
  • Pietenpol JA, Stein RW, Moran E, Yaciuk P, Schlegel R, Lyons RM, Pittelkow MR, Münger K, Howley PM, Moses HL. TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell. 1990 Jun 1;61(5):777–785. [PubMed] [Google Scholar]
  • Pines J, Hunter T. Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport. J Cell Biol. 1991 Oct;115(1):1–17. [PMC free article] [PubMed] [Google Scholar]
  • Posada J, Cooper JA. Requirements for phosphorylation of MAP kinase during meiosis in Xenopus oocytes. Science. 1992 Jan 10;255(5041):212–215. [PubMed] [Google Scholar]
  • Posada J, Sanghera J, Pelech S, Aebersold R, Cooper JA. Tyrosine phosphorylation and activation of homologous protein kinases during oocyte maturation and mitogenic activation of fibroblasts. Mol Cell Biol. 1991 May;11(5):2517–2528. [PMC free article] [PubMed] [Google Scholar]
  • Prendergast GC, Hopewell R, Gorham BJ, Ziff EB. Biphasic effect of Max on Myc cotransformation activity and dependence on amino- and carboxy-terminal Max functions. Genes Dev. 1992 Dec;6(12A):2429–2439. [PubMed] [Google Scholar]
  • Prendergast GC, Lawe D, Ziff EB. Association of Myn, the murine homolog of max, with c-Myc stimulates methylation-sensitive DNA binding and ras cotransformation. Cell. 1991 May 3;65(3):395–407. [PubMed] [Google Scholar]
  • Prendergast GC, Ziff EB. Methylation-sensitive sequence-specific DNA binding by the c-Myc basic region. Science. 1991 Jan 11;251(4990):186–189. [PubMed] [Google Scholar]
  • Prendergast GC, Ziff EB. A new bind for Myc. Trends Genet. 1992 Mar;8(3):91–96. [PubMed] [Google Scholar]
  • Prochownik EV, Kukowska J. Deregulated expression of c-myc by murine erythroleukaemia cells prevents differentiation. Nature. 322(6082):848–850. [PubMed] [Google Scholar]
  • Pulverer BJ, Kyriakis JM, Avruch J, Nikolakaki E, Woodgett JR. Phosphorylation of c-jun mediated by MAP kinases. Nature. 1991 Oct 17;353(6345):670–674. [PubMed] [Google Scholar]
  • Rabbitts PH, Watson JV, Lamond A, Forster A, Stinson MA, Evan G, Fischer W, Atherton E, Sheppard R, Rabbitts TH. Metabolism of c-myc gene products: c-myc mRNA and protein expression in the cell cycle. EMBO J. 1985 Aug;4(8):2009–2015. [PMC free article] [PubMed] [Google Scholar]
  • Roussel MF, Cleveland JL, Shurtleff SA, Sherr CJ. Myc rescue of a mutant CSF-1 receptor impaired in mitogenic signalling. Nature. 1991 Sep 26;353(6342):361–363. [PubMed] [Google Scholar]
  • Rustgi AK, Dyson N, Bernards R. Amino-terminal domains of c-myc and N-myc proteins mediate binding to the retinoblastoma gene product. Nature. 1991 Aug 8;352(6335):541–544. [PubMed] [Google Scholar]
  • Saksela K, Mäkelä TP, Hughes K, Woodgett JR, Alitalo K. Activation of protein kinase C increases phosphorylation of the L-myc trans-activator domain at a GSK-3 target site. Oncogene. 1992 Feb;7(2):347–353. [PubMed] [Google Scholar]
  • Sanghera JS, Paddon HB, Pelech SL. Role of protein phosphorylation in the maturation-induced activation of a myelin basic protein kinase from sea star oocytes. J Biol Chem. 1991 Apr 15;266(11):6700–6707. [PubMed] [Google Scholar]
  • Seth A, Alvarez E, Gupta S, Davis RJ. A phosphorylation site located in the NH2-terminal domain of c-Myc increases transactivation of gene expression. J Biol Chem. 1991 Dec 15;266(35):23521–23524. [PubMed] [Google Scholar]
  • Seth A, Gonzalez FA, Gupta S, Raden DL, Davis RJ. Signal transduction within the nucleus by mitogen-activated protein kinase. J Biol Chem. 1992 Dec 5;267(34):24796–24804. [PubMed] [Google Scholar]
  • Shi Y, Glynn JM, Guilbert LJ, Cotter TG, Bissonnette RP, Green DR. Role for c-myc in activation-induced apoptotic cell death in T cell hybridomas. Science. 1992 Jul 10;257(5067):212–214. [PubMed] [Google Scholar]
  • Shibuya EK, Boulton TG, Cobb MH, Ruderman JV. Activation of p42 MAP kinase and the release of oocytes from cell cycle arrest. EMBO J. 1992 Nov;11(11):3963–3975. [PMC free article] [PubMed] [Google Scholar]
  • Shibuya H, Yoneyama M, Ninomiya-Tsuji J, Matsumoto K, Taniguchi T. IL-2 and EGF receptors stimulate the hematopoietic cell cycle via different signaling pathways: demonstration of a novel role for c-myc. Cell. 1992 Jul 10;70(1):57–67. [PubMed] [Google Scholar]
  • Sorrentino V, Drozdoff V, McKinney MD, Zeitz L, Fleissner E. Potentiation of growth factor activity by exogenous c-myc expression. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8167–8171. [PMC free article] [PubMed] [Google Scholar]
  • Stern DF, Roberts AB, Roche NS, Sporn MB, Weinberg RA. Differential responsiveness of myc- and ras-transfected cells to growth factors: selective stimulation of myc-transfected cells by epidermal growth factor. Mol Cell Biol. 1986 Mar;6(3):870–877. [PMC free article] [PubMed] [Google Scholar]
  • Stokoe D, Campbell DG, Nakielny S, Hidaka H, Leevers SJ, Marshall C, Cohen P. MAPKAP kinase-2; a novel protein kinase activated by mitogen-activated protein kinase. EMBO J. 1992 Nov;11(11):3985–3994. [PMC free article] [PubMed] [Google Scholar]
  • Street AJ, Blackwood E, Lüscher B, Eisenman RN. Mutational analysis of the carboxy-terminal casein kinase II phosphorylation site in human c-myc. Curr Top Microbiol Immunol. 1990;166:251–258. [PubMed] [Google Scholar]
  • Sturgill TW, Ray LB, Erikson E, Maller JL. Insulin-stimulated MAP-2 kinase phosphorylates and activates ribosomal protein S6 kinase II. Nature. 1988 Aug 25;334(6184):715–718. [PubMed] [Google Scholar]
  • Takishima K, Griswold-Prenner I, Ingebritsen T, Rosner MR. Epidermal growth factor (EGF) receptor T669 peptide kinase from 3T3-L1 cells is an EGF-stimulated "MAP" kinase. Proc Natl Acad Sci U S A. 1991 Mar 15;88(6):2520–2524. [PMC free article] [PubMed] [Google Scholar]
  • Tamemoto H, Kadowaki T, Tobe K, Ueki K, Izumi T, Chatani Y, Kohno M, Kasuga M, Yazaki Y, Akanuma Y. Biphasic activation of two mitogen-activated protein kinases during the cell cycle in mammalian cells. J Biol Chem. 1992 Oct 5;267(28):20293–20297. [PubMed] [Google Scholar]
  • Tate EH, Wilder ME, Cram LS, Wharton W. A method for staining 3T3 cell nuclei with propidium iodide in hypotonic solution. Cytometry. 1983 Nov;4(3):211–215. [PubMed] [Google Scholar]
  • Thompson CB, Challoner PB, Neiman PE, Groudine M. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature. 314(6009):363–366. [PubMed] [Google Scholar]
  • Tobey RA, Oishi N, Crissman HA. Cell cycle synchronization: reversible induction of G2 synchrony in cultured rodent and human diploid fibroblasts. Proc Natl Acad Sci U S A. 1990 Jul;87(13):5104–5108. [PMC free article] [PubMed] [Google Scholar]
  • Torres R, Schreiber-Agus N, Morgenbesser SD, DePinho RA. Myc and Max: a putative transcriptional complex in search of a cellular target. Curr Opin Cell Biol. 1992 Jun;4(3):468–474. [PubMed] [Google Scholar]
  • Waitz W, Loidl P. Cell cycle dependent association of c-myc protein with the nuclear matrix. Oncogene. 1991 Jan;6(1):29–35. [PubMed] [Google Scholar]
  • Waters CM, Littlewood TD, Hancock DC, Moore JP, Evan GI. c-myc protein expression in untransformed fibroblasts. Oncogene. 1991 May;6(5):797–805. [PubMed] [Google Scholar]
  • Weinberg RA. Tumor suppressor genes. Science. 1991 Nov 22;254(5035):1138–1146. [PubMed] [Google Scholar]
  • Woodford TA, Pardee AB. Histone H1 kinase in exponential and synchronous populations of Chinese hamster fibroblasts. J Biol Chem. 1986 Apr 5;261(10):4669–4676. [PubMed] [Google Scholar]
  • Zervos AS, Gyuris J, Brent R. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites. Cell. 1993 Jan 29;72(2):223–232. [PubMed] [Google Scholar]
Articles from Molecular and Cellular Biology are provided here courtesy of American Society for Microbiology (ASM)